France Market Access Director – Oncology & HTA

Genmab A/S; Paris; Hybride; EUR 80 000 - 100 000; Plein temps

Résumé du poste

An international biotechnology company is seeking a Market Access Pricing and Public Affairs Director to lead the development of market access strategies for its oncology pipeline. This role requires 10 to 15 years of experience in market access, a strong network in France, and excellent negotiation skills. The director will oversee HTA submissions, drive public affairs planning, and collaborate with internal and external stakeholders to secure favorable pricing and access conditions. Fluency in the local language and business English is necessary.

Qualifications

• 10 to 15 years of experience within Market Access & pricing.
• Strong network in France.
• Strong knowledge of the market access & pricing landscape.
• Strong oncology market knowledge.
• Excellent communication and negotiation skills.
• Business fluency in English.
• Fluency in local language is a must.

Responsabilités

• Lead development of French Market Access strategy.
• Drive development of HTA submissions and P&R negotiations.
• Analyze P&R policy and communications with stakeholders.
• Contribute to strategy discussions with external stakeholders.
• Develop local market access deliverables.

Connaissances

Market Access experience

Stakeholder engagement

Negotiation skills

Oncology knowledge

Communication skills

Fluency in local language

Business English

Description du poste

An international biotechnology company is seeking a Market Access Pricing and Public Affairs Director to lead the development of market access strategies for its oncology pipeline. This role requires 10 to 15 years of experience in market access, a strong network in France, and excellent negotiation skills. The director will oversee HTA submissions, drive public affairs planning, and collaborate with internal and external stakeholders to secure favorable pricing and access conditions. Fluency in the local language and business English is necessary.